Cargando…

A Global Effort to Define the Human Genetics of Protective Immunity to SARS-CoV-2 Infection

SARS-CoV-2 infection displays immense inter-individual clinical variability, ranging from silent infection to lethal disease. The role of human genetics in determining clinical response to the virus remains unclear. Studies of outliers—individuals remaining uninfected despite viral exposure and heal...

Descripción completa

Detalles Bibliográficos
Autores principales:	Casanova, Jean-Laurent, Su, Helen C.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Elsevier Inc. 2020
Materias:	Commentary
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7218368/ https://www.ncbi.nlm.nih.gov/pubmed/32405102 http://dx.doi.org/10.1016/j.cell.2020.05.016

Ejemplares similares

A global effort to dissect the human genetic basis of resistance to SARS-CoV-2 infection
por: Andreakos, Evangelos, et al.
Publicado: (2021)

Author Correction: A global effort to dissect the human genetic basis of resistance to SARS-CoV-2 infection
por: Andreakos, Evangelos, et al.
Publicado: (2021)

Lessons from a local effort to screen for SARS-CoV-2
por: Silverstein, Noah J., et al.
Publicado: (2021)

Harnessing Type I IFN Immunity Against SARS-CoV-2 with Early Administration of IFN-β
por: Vinh, Donald C., et al.
Publicado: (2021)

Pregnant people deserve the protection offered by SARS-CoV-2 vaccines
por: Maykin, Melanie M., et al.
Publicado: (2021)

Current Clinical Trials Protocols and the Global Effort for Immunization against SARS-CoV-2
por: Rego, Gabriel N. A., et al.
Publicado: (2020)

SARS-CoV-2 vaccine for domestic and captive animals: An effort to counter COVID-19 pandemic at the human-animal interface
por: Sharun, Khan, et al.
Publicado: (2021)

IgM responses following SARS-CoV-2 vaccination: insights into protective and pre-existing immunity
por: Fraussen, Judith
Publicado: (2022)

Women’s Leadership in Global Health Efforts
Publicado: (2023)

Implementing digital passports for SARS-CoV-2 immunization in Canada
por: Wilson, Kumanan, et al.
Publicado: (2021)

A framework for monitoring population immunity to SARS-CoV-2
por: Lopman, Benjamin A., et al.
Publicado: (2021)

Low genetic diversity may be an Achilles heel of SARS-CoV-2
por: Rausch, Jason W., et al.
Publicado: (2020)

Detect to protect: pneumoperitoneum gas samples for SARS-CoV-2 and biohazard testing
por: Cicuttin, Enrico, et al.
Publicado: (2020)

SARS‐CoV‐2 Omicron variant: Why global communities should take it seriously?
por: Rahmani, Shayan, et al.
Publicado: (2022)

The paramount importance of serological surveys of SARS-CoV-2 infection and immunity
por: Goudsmit, Jaap
Publicado: (2020)

SARS-CoV-2 vaccination for immune-comprised patients: More is required
por: Li, Hui, et al.
Publicado: (2021)

Acute exercise and immune response in previously SARS CoV-2 infection
por: Sookaromdee, Pathum, et al.
Publicado: (2021)

COVID 19, Paxlovid and the lesson from rare genetic diseases with naturally occurring protection from SARS-CoV-2 infection
por: Calò, Lorenzo A., et al.
Publicado: (2022)

The potential of developing a protective peptide‐based vaccines against SARS‐CoV‐2
por: Shalash, Ahmed O., et al.
Publicado: (2022)

Artificial intelligence and clinical data suggest the T cell-mediated SARS-CoV-2 nonstructural protein intranasal vaccines for global COVID-19 immunity
por: Seyran, Murat
Publicado: (2022)

The Indirect Benefit on Respiratory Health From the World’s Effort to Reduce Transmission of SARS-CoV-2
por: Dutheil, Frédéric, et al.
Publicado: (2020)

Genetic Variants and Protective Immunity against SARS-CoV-2
por: Rabaan, Ali A., et al.
Publicado: (2022)

Inborn errors of immunity to infection: the rule rather than the exception
por: Casanova, Jean-Laurent, et al.
Publicado: (2005)

Human Mannose-binding Lectin in Immunity: Friend, Foe, or Both?
por: Casanova, Jean-Laurent, et al.
Publicado: (2004)

Protective measures for patients with advanced cancer during the Sars-CoV-2 pandemic: Quo vadis?
por: Ivanyi, P., et al.
Publicado: (2021)

Do not blame bats and pangolins! Global consequences for wildlife conservation after the SARS-CoV-2 pandemic
por: Turcios-Casco, Manfredo A., et al.
Publicado: (2020)

Pathogenicity of SARS‐CoV‐2 Omicron
por: Chu, Hin, et al.
Publicado: (2022)

Antigenic imprinting in SARS‐CoV‐2
por: Reincke, S. Momsen, et al.
Publicado: (2022)

Platelet size as a mirror for the immune response after SARS‐CoV‐2 vaccination
por: Thiele, Thomas, et al.
Publicado: (2022)

Unleashing immuno-mass spectrometry superpowers to detect SARS-CoV-2
por: Armengaud, Jean
Publicado: (2021)

Protecting clinical trials in cystic fibrosis during the SARS-CoV-2 pandemic: risks and mitigation measures
por: van Koningsbruggen-Rietschel, Silke, et al.
Publicado: (2021)

No credible evidence supporting claims of the laboratory engineering of SARS-CoV-2
por: Liu, Shan-Lu, et al.
Publicado: (2020)

The Neuroimmune Pharmacology of SARS-CoV-2
por: Kumar, Santosh, et al.
Publicado: (2021)

Immune response to SARS-CoV-2 infection and vaccination in patients receiving kidney replacement therapy
por: Ikizler, T. Alp, et al.
Publicado: (2021)

Glimpses into evolutionary trajectories of SARS-CoV-2: emerging variants and potential immune evasion routes
por: Anastassopoulou, Cleo, et al.
Publicado: (2021)

Tuberculosis in children and adults: two distinct genetic diseases
por: Alcaïs, Alexandre, et al.
Publicado: (2005)

SARS‐CoV‐2: March toward adaptation
por: Benedetti, Francesca, et al.
Publicado: (2020)

The pathogenesis and alternative treatment of SARS-CoV2
por: Choi, Jun-Yong, et al.
Publicado: (2020)

The prospects for the SARS‐CoV‐2 pandemic in Africa
por: Quaresima, Virginia, et al.
Publicado: (2020)

One year of SARS-CoV-2 evolution
por: Wu, Aiping, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_4gels5pconjchupo0qca0htsj4